Transfektionsvorrichtung mit Sericinhydrolysat

Patent europeic · EP2194116 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2194116
Numer da la dumonda
EP08828531
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-08-2008
Publitgà
09-06-2010
Concedì
06-08-2014
La protecziun finescha il pli tard
21-08-2028
Proxima taxa annuala scadenta
31-08-2026
Classas IPC
C12N 15/11 (2006.01)
C12N 15/87 (2006.01)
Prioritad
JP 2007218733 24.08.2007
Dumonda PCT
PCT/JP2008/065027 22.08.2008
Publicaziun PCT
WO2009/028421 05.03.2009
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-12-2025

    Midada

    Published in Swissreg on 02.12.2025

  2. 29-11-2024

    Midada

    Published in Swissreg on 29.11.2024

  3. 30-11-2023

    Midada

    Published in Swissreg on 30.11.2023

  4. 28-02-2023

    Midada

    Published in Swissreg on 28.02.2023

  5. 06-08-2014

    Concedì

    Published in Swissreg on 06.08.2014

Partidas

Possessur

CytoPathfinder, Inc.

8-10, Nihombashimuro-machi, 1-Chome Chuo-ku, Tokyo 103-0022, JP

Inventur

FUJITA, Yoshiji

Tokyo 103-0022, JP

YOSHIKAWA, Tomohiro

Tokyo 103-0022, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.